# Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

> **NCT05035849** · NA · COMPLETED · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 60 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** sitagliptin and acarbose

## Key facts

- **NCT ID:** NCT05035849
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-30
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-05-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05035849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05035849, "Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05035849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*